Home › Novo Nordisk - Saxenda Provides Added Value That The Market May Not Appreciate
 

Keywords :   


Novo Nordisk - Saxenda Provides Added Value That The Market May Not Appreciate

2016-03-14 19:19:38| Biotech - Topix.net

Novo Nordisk has secret weapons of sorts when it comes to entering the anti-obesity space. The first secret weapon is that the main ingredient in the anti-obesity drug Saxenda is the same ingredient, liraglutide, in the already successful diabetes drug Victoza.

Tags: not added market novo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05Farm Progress America, May 20, 2024
20.05Farm Progress America, May 20, 2024
20.05Nielsen launches The Media Distributor Gauge
20.05Minerva AI Companion enhances the TV viewing experience
20.05Ryanair profits surge after fares climb by 20%
20.05SES Ethiosat delivering content to 95% of TV homes in Ethiopia
More »